{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:23:03Z","timestamp":1791973383494,"version":"4.3.4"},"reference-count":64,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2009,1,1]]},"DOI":"10.1185\/03007990802576518","type":"journal-article","created":{"date-parts":[[2009,6,27]],"date-time":"2009-06-27T16:42:56Z","timestamp":1246120976000},"page":"23-37","source":"Crossref","is-referenced-by-count":41,"title":["Goal-oriented therapy with miglustat in Gaucher disease"],"prefix":"10.1185","volume":"25","author":[{"given":"Gregory M.","family":"Pastores","sequence":"first","affiliation":[{"name":"Neurology and Pediatrics, New York University School of Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Giraldo","sequence":"additional","affiliation":[{"name":"Miguel Servet University Hospital, Zaragoza, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ch\u00e9rin","sequence":"additional","affiliation":[{"name":"M\u00e9decine Interne, Piti\u00e9-Salp\u00eatri\u00e8re, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Mehta","sequence":"additional","affiliation":[{"name":"Royal Free Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2008,11,21]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.18.2835"},{"key":"CIT0002","first-page":"2641","volume-title":"The Metabolic and Molecular Basis of Inherited Disease","author":"Beutler E","year":"1995"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(97)80033-9"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-7192(02)00122-1"},{"key":"CIT0005","first-page":"3635","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Beutler E","year":"2001"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20676"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1023\/B:BOLI.0000005623.60471.51"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-3787(06)75120-7"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2004.08.015"},{"key":"CIT0010","unstructured":"Hollak CE, Biegstraaten M Van Schaik, in et al. Prevalence of polyneuropathy in adult Type 1 Gaucher disease (GD1): a multinational prospective observational study. Poster presented at the 2007 Annual Congress of the Society of the Study of Inborn Errors of Metabolism (SSIEM), Hamburg, Germany, September 4\u20137"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2004.07.009"},{"key":"CIT0012","unstructured":"Genzyme Corporation. Cerezyme\u00ae (imiglucerase for injection) Prescribing Information. Available at: http:\/\/www.cerezyme.com\/global\/pi.pdf [Last accessed 18 July 2008]"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","volume":"269","author":"Platt FM","year":"1994","journal-title":"J Biol Chem"},{"key":"CIT0014","unstructured":"Miglustat Summary of Product Characteristics. Available at: http:\/\/www.emea.europa.eu\/humandocs\/Humans\/EPAR\/zavesca\/zavesca.htm [Last accessed 20 October 2008]"},{"key":"CIT0015","unstructured":"Actelion Pharmaceuticals US, Inc. Zavesca\u00ae (miglustat capsules) Prescribing Information. Available at: http:\/\/www.zavesca.com\/pdfs\/zavesca_pi.pdf [Last accessed 18 July 2008]"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02161-9"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1023\/B:BOLI.0000045756.54006.17"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.08.004"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.08.006"},{"key":"CIT0020","first-page":"703","volume":"91","author":"Giraldo P","year":"2006","journal-title":"Haematologica"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-075960"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.75.suppl_1.750002"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2006.00573.x"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.160.6.603"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-004-0794-y"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198509000-00003"},{"key":"CIT0027","unstructured":"Kolodny EH, Ullman MD, Mankin HJ, et al. Phenotypic manifestations of Gaucher disease clinical features in 48 biochemically verified Type 1 Gaucher patients and comment on Type 2 patients. In: Desnick RJ, Gatt S, Grabowski GA, eds. Gaucher Disease: a Century of Delineation and Research. New York: Alan R Liss, 1982, pp. 33-65"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650111125"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2007.04.012"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-003-1363-z"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X104623"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-007-0425-0"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1080\/00498250601094543"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FMJ05004X3"},{"key":"CIT0035","doi-asserted-by":"crossref","unstructured":"Mikosch P, Reed M, Baker C, et al. Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat. Calcif Tissue Int 2008;83:43-54","DOI":"10.1007\/s00223-008-9143-4"},{"key":"CIT0036","unstructured":"Hollak CEM, van Weely S, Maas M, et al. Bone disease and Zavesca\u2122 (miglustat) \u2013 new insights and results. Poster presented at the 2004 Annual Congress of the Society of the Study of Inborn Errors of Metabolism (SSIEM), Amsterdam, The Netherlands, 31 August\u20133 September"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-006-0272-5"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.75.suppl_1.750025"},{"key":"CIT0039","unstructured":"Roca M, Latre P, Alfonso C, et al. Bone densitometry usefully in the evaluation of bone disease in type 1 Gaucher patients. A preliminary comparative study. Poster presented at the 2008 conference of the European Working Group on Gaucher Disease (EWGGD), Budapest, Hungary, 4-7 June"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008878425167"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01150-6"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2006.07.003"},{"key":"CIT0043","unstructured":"Heitner R, Hrebicek M, Elstein C, et al. An open-label study of 5-years treatment with miglustat in adult patients with type 1 Gaucher disease. Poster presented at the 54th Annual Meeting of the American Society of Human Genetics (ASH-G), New Orleans, USA, 9\u201313 October, 2006"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.160.3.3526400"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-11-199612010-00005"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10194-0"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.02.038"},{"key":"CIT0048","unstructured":"Schiffmann R, Harris C, DeVile C, et al. Miglustat in Gaucher et al. disease Type 3: a randomized controlled study with a non-comparative extension phase. Ann Neurol 2008 (in press)"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012492429191"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.1999.0237"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1612"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117084"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1007\/BF02682034"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2006.07.010"},{"key":"CIT0055","unstructured":"Hollak C, Hughes D, van Schaik IN, et al. Miglustat (Zavesca) in type 1 Gaucher disease: results of a post-marketing surveillance programme. Poster presented at the 2008 conference of the European Working Group on Gaucher Disease (EWGGD), Budapest, Hungary, 4\u20137 June"},{"key":"CIT0056","first-page":"59","volume":"81","author":"Batiecie L","year":"2008","journal-title":"Croat Chem Acta"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/113.4.855"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025902113005"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.2002.0497"},{"key":"CIT0060","unstructured":"Elstein D, Dweck A, Attias D, et al. Oral maintenance of miglustat in adult patients with type 1 Gaucher disease: the patients\u2019 quality of life perspective. Poster presented at the 2007 Annual Congress of the Society of the Study of Inborn Errors of Metabolism (SSIEM), Hamburg, Germany, 4\u20137 September"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3854"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-12-5072"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-010801"},{"key":"CIT0064","unstructured":"Jaussaud R, Javier RM, Rose C, et al. French Observatoire on Gaucher disease (FROG): results on 107 patients. Abstract presented at the 2007 Annual Congress of the Society of the Study of Inborn Errors of Metabolism (SSIEM), Hamburg, Germany, 4\u20137 September (422-P)"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007990802576518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T23:06:13Z","timestamp":1633647973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007990802576518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,21]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1,1]]}},"alternative-id":["10.1185\/03007990802576518"],"URL":"https:\/\/doi.org\/10.1185\/03007990802576518","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,21]]}}}